A critical role for expression of atypical chemokine receptor 2 in multiple sclerosis: a preliminary project

Conclusion: Our data clearly show a decreased ACKR2 mRNA expression on PBMCs and increased plasma IL-33 levels of patients with MS. There was no significant relationship between ACKR2 and other cytokine levels. Within our knowledge, this is the first study that evaluates the ACKR2 mRNA expression in the PBMCs of MS patients.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research